Search Results
The Therapeutic Potential of Novel PARP Inhibitors in the Clinic for Epithelial Ovarian Cancer
The Clinical Potential of Novel PARP Inhibitors for Improved Management of Epithelial Ovarian Cancer
Expert Perspectives: The Clinical Potential of PARP Inhibitors in Ovarian Cancer
Ongoing Clinical Trials with PARP Inhibitors in Ovarian Cancer
Clinical Data with PARP Inhibitors in Ovarian Cancer
Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches
The promising potential of PARP inhibitors in ovarian cancer
Testing for BRCA Germline Mutations in the Clinic and the Mechanism of Action of PARP Inhibitors
PARP Inhibitors
What is a PARP Inhibitor? | Dana-Farber Cancer Institute | Science Illustrated
Ovarian Cancer: The Role of PARP Inhibitors and Beyond
Differences Among PARP Inhibitors in Ovarian Cancer